Literature DB >> 17353290

Murine aerosol challenge model of anthrax.

Crystal L Loving1, Mary Kennett, Gloria M Lee, Vanessa K Grippe, Tod J Merkel.   

Abstract

The availability of relevant and useful animal models is critical for progress in the development of effective vaccines and therapeutics. The infection of rabbits and non-human primates with fully virulent Bacillus anthracis spores provides two excellent models of anthrax disease. However, the high cost of procuring and housing these animals and the specialized facilities required to deliver fully virulent spores limit their practical use in early stages of product development. Conversely, the small size and low cost associated with using mice makes this animal model more practical for conducting experiments in which large numbers of animals are required. In addition, the availability of knockout strains and well-characterized immunological reagents makes it possible to perform studies in mice that cannot be performed easily in other species. Although we, along with others, have used the mouse aerosol challenge model to examine the outcome of B. anthracis infection, a detailed characterization of the disease is lacking. The current study utilizes a murine aerosol challenge model to investigate disease progression, innate cytokine responses, and histological changes during the course of anthrax after challenge with aerosolized spores. Our results show that anthrax disease progression in a complement-deficient mouse after challenge with aerosolized Sterne spores is similar to that described for other species, including rabbits and non-human primates, challenged with fully virulent B. anthracis. Thus, the murine aerosol challenge model is both useful and relevant and provides a means to further investigate the host response and mechanisms of B. anthracis pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353290      PMCID: PMC1932896          DOI: 10.1128/IAI.01875-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Experimental models of pulmonary infection.

Authors:  Irma A J M Bakker-Woudenberg
Journal:  J Microbiol Methods       Date:  2003-09       Impact factor: 2.363

Review 2.  Introduction: anthrax history, disease and ecology.

Authors:  P C B Turnbull
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 3.  Bacillus anthracis cell envelope components.

Authors:  A Fouet; S Mesnage
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

4.  Identification and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis.

Authors:  C Guidi-Rontani; Y Pereira; S Ruffie; J C Sirard; M Weber-Levy; M Mock
Journal:  Mol Microbiol       Date:  1999-07       Impact factor: 3.501

5.  Macrophage-enhanced germination of Bacillus anthracis endospores requires gerS.

Authors:  John A W Ireland; Philip C Hanna
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores.

Authors:  Alison K Pickering; Tod J Merkel
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 7.  Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.

Authors:  Taro Fukao
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

8.  Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis).

Authors:  Daphne Vasconcelos; Roy Barnewall; Michael Babin; Robert Hunt; James Estep; Carl Nielsen; Robert Carnes; John Carney
Journal:  Lab Invest       Date:  2003-08       Impact factor: 5.662

9.  The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain.

Authors:  Uwe Ritter; Jochen Mattner; Janaina Soares Rocha; Christian Bogdan; Heinrich Körner
Journal:  Microbes Infect       Date:  2004-05       Impact factor: 2.700

10.  Time-lapse confocal imaging of development of Bacillus anthracis in macrophages.

Authors:  Gordon Ruthel; Wilson J Ribot; Sina Bavari; Timothy A Hoover
Journal:  J Infect Dis       Date:  2004-03-19       Impact factor: 5.226

View more
  34 in total

1.  Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities.

Authors:  Tod J Merkel; Pin-Yu Perera; Vanessa K Kelly; Anita Verma; Zara N Llewellyn; Thomas A Waldmann; Joseph D Mosca; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 3.  The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected Host.

Authors:  George C Stewart
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

4.  Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.

Authors:  Manuel Osorio; Yanping Wu; Sunil Singh; Tod J Merkel; Siba Bhattacharyya; Milan S Blake; Dennis J Kopecko
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

5.  Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection.

Authors:  David E Lowe; Stephen M C Ernst; Christine Zito; Jason Ya; Ian J Glomski
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

6.  Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant.

Authors:  Brandon Feinen; Nikolai Petrovsky; Anita Verma; Tod J Merkel
Journal:  Clin Vaccine Immunol       Date:  2014-02-19

7.  Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.

Authors:  Crystal L Loving; Taruna Khurana; Manuel Osorio; Gloria M Lee; Vanessa K Kelly; Scott Stibitz; Tod J Merkel
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

8.  Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.

Authors:  Hitendra S Chand; Melissa Drysdale; Julie Lovchik; Theresa M Koehler; Mary F Lipscomb; C Rick Lyons
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

9.  Nod1/Nod2-mediated recognition plays a critical role in induction of adaptive immunity to anthrax after aerosol exposure.

Authors:  Crystal L Loving; Manuel Osorio; Yun-Gi Kim; Gabriel Nuñez; Molly A Hughes; Tod J Merkel
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

10.  Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Authors:  Vladimir Savransky; Daniel C Sanford; Emily Syar; Jamie L Austin; Kevin P Tordoff; Michael S Anderson; Gregory V Stark; Roy E Barnewall; Crystal M Briscoe; Laurence Lemiale-Biérinx; Sukjoon Park; Boris Ionin; Mario H Skiadopoulos
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.